A method for isolating regulatory mutants for the synthesis of lysine biosynthetic enzymes in Escherichia coli is described. One of them is identified as a cis-dominant constitutive mutant for the synthesis of the lysine-sensitive asportokinase AK III (lysC gene).
To the best of our knowledge no mutation impairing regulation of the synthesis of one or several enzymes of the lysine biosynthetic pathway has been described in Escherichia coli. The following features may account for the inability to isolate such mutants. (i) The first two reactions are the common part of the branched biosynthetic pathway of the aspartate family of amino acids in which isofunctional and multifunctional enzymes have been described (14) (Fig. 1); (ii) the genes known to specify eight of the nine enzymes of the lysine pathway are scattered along the chromosome (20, 21) ; and (iii) feedback inhibition seems to play a prominent role in the regulation of this pathway. We have been able to select many mutants that excrete lysine in the growth medium, thus overcoming the growth inhibition of the wildtype strain exerted by lysine analogues. Most of them appeared to have an aspartokinase III (AK III; EC 2.7.2.4) activity which was partially or totally desensitized towards lysine; the mutations were localized in the lysC gene specifying this enzyme (2, 21) .
In a general study of the overall regulation of this pathway, we have recently isolated regulatory mutants by a procedure taking the three above-mentioned features into account. In this paper the isolation procedure and the characterization of one of the mutants, a cis-dominant constitutive mutant of the lysC gene, are described.
MATERIAL AND METHODS Bacterial strains. All strains were derived from E. coli K-12. Phenotypes and genotypes are given in Table 1 . Allele numbers were allocated to the Service de Biochimie Cellulaire, Institut Pasteur, by the E. coli Genetic Stock Center of Yale University.
Transduction. Transduction with phage Plkc was performed according to the method of Lennox (9) .
Mutagenesis. Mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine and penicillin selection are described in reference 1. Preparation of recA derivatives. This involved the following steps: (i) preparation of Thy-derivatives, selecting for trimethoprim resistance (19) ; (ii) selection of Thy+ recombinants after 30 min of mating with Hfr KL 16-6; (iii) identification of recA recombinants by comparing their ultraviolet sensitivity (4) with that of rec+ and recA control strains.
Preparation of stable merodiploids. All merodipl&fds described in Table 1 
RESULTS
Isolation of regulatory mutants. To overcome presumed difficulties, the following procedure was used. The parental strain, Gif 106, lacking AK I and AK II activities, is able to grow in minimal medium. Lysine addition inhibits growth, however, owing to inhibition and repression of AK III, the only remaining enzyme that is able to catalyze aspartylphosphate syn- bDoes not grow exponentially in these conditions. most strains were identical to those observed with the parental strain G21 M22 (Table 3) . It must be noted that the AK III specif'ic activity of' strain G21 M22 is much higher than that of' the parental strain 106 G21; this may be explained by a lower internal pool of lysine, owing to the leaky ASA-dehydrogenase activity. The AK III specific activity of' 20 of' the strains was significantly higher than with strain G21 M22 when growth occurred in the absence of' lvsine, but a normal repression pattern was observed when 4 mM L-lysine was added to the growth medium (strain OR K20 is given as an example). The two other strains (ORA 11 and ORA 19) led to different results (Table 3) : AK III specific activity was highly derepressed when cells were grown in minimal medium, and a high level of activity was also observed when growth was effected in the repressed conditions, indicating a partially constitutive synthesis of AK III in these strains. Similar results were obtained when the lysine concentration was raised to 100 mM (instead of 4 mM). Results with strain ORA 19 were identical to those observed with strain ORA 11. Characterization of the mutation. These preliminary observations (apparent partial constitutivity) were compatible with the mutation in strain ORA 11 (lys-1100) being a cis-dominant constitutive (operator-type) or a promoter-up mutation for AK III synthesis. Its co-transducibility with mutations in the lysC gene was therefore investigated. Transduction was performed using ORA 11 (lys-llOO, lysC1002) as donor and 106 Ml (lysClOO1) as recipient (in this strain, lysC1O01 mutation leads to an auxotrophic requirement t'or homoserine plus diaminopimelate). Transductants growing in the absence of' these amino acids (LysC+ phenotype) were selected. At'ter reisolation of' 50 clones, the inhibition of' growth in the presence of' lysine was tested. Inhibition occurred for two of' 50 strains tested. These two strains and five other transductants (among the clones resistant to lysine inhibition of' growth) were grown in the repressed conditions, and their AK III specific activity was measured in crude extracts. In all cases a not completely repressible synthesis of' AK III was observed, indicating that all strains have received the lys-1100 mutation from strain ORA 11. In the case of the five colonies resistant to lysine inhibition, the AK III activity was desensitized towards lysine inhibition (owing to the presence of' the lysClO02 mutation); strain ORA 103 was one of them.
In the two strains whose growth was inhibited by lysine, the AK III activity was sensitive to lysine inhibition. These strains have the 1XsC+ gene. Thus, both mutations IysC1001 and IysC1002 were lost during the recombination events. The presence of' lysine in the growth medium is sufficient to inhibit AK III activity and prevent aspartylphosphate synthesis, even though the synthesis of' this enzyme is not completely repressed. These two strains are thus isogenic to the parental strain Gif' 106, except for the lys-llOO mutation. One of' them, strain ORA 101, was studied in detail. Table 4 indicates that normal levels of ASAdehydrogenase and diaminopimelate decarboxylase, enzymes under the repressive control by lysine (2, 15) , are obtained with strain ORA 101 grown in minimal medium; AK III synthesis is highly derepressed in minimal medium and partially constitutive in the repressed conditions.
The fact that the lys-1100 mutation is cotransducible with lysC mutations and that the synthesis of two other enzymes of the pathway appear unmodified in strains carrying this mutation is in agreement with the hypothesis that the lys-1100 mutation could be either a cis-dominant constitutive or a promoter-up mutation.
Localization of the mutation. A more precise localization of the lys-1100 mutation required a higher number of transductants. Therefore, the following experiment, which takes into account the phenotype (resistance to growth inhibition by lysine) exhibited by strains carrying the Iys-ilOO mutation in the presence of the asdllOl and lysC1002 mutations, was performed. Phage grown on strain ORA 11 (lys-1100, lysC1002, asdl 101) was used as a donor in a transduction in which the recipient was G21 Mlll (lysC1010, lysC1002, asdllOl). LysC+ transductants (growing in the absence of homoserine plus diaminopimelate) were selected. The inhibition of growth in the presence of lysine was tested by the replica plating on agar medium containing 10 mM L-lysine of master plates taken after only 10 h of growth. Complete resistance to lysine inhibition (normal growth after 16-h incubation) was observed for 98% of the transductants (over 450); for the other 2% (nine "sensitive" colonies) growth was delayed for 24 h. To ensure the correlation It thus appears that the lys-llOO mutation is 98% co-transducible with the lysCi100 mutation of strain G21 Mill, confirming the high co-transducibility with the IysClOO1 mutation of strain 106 Ml observed in the preliminary experiment.
Dominance tests. The possibilitv that the lys-1100 mutation is a cis-dominant constitutive one was tested by dominance studies using episomes carrying part of the bacterial chromosome with a lysC+ gene.
Strain ORA 161 (recA derivative of ORA 101) was used to select a lysC mutant in which AK III was desensitized towards lysine inhibition. The selective procedure which employed resistance to lysine-mediated growth inhibition (2) resulted in the isolation of strain OR 162 (mutation lysC1012). Merodipldids were then prepared by conjugation of F-strains OR 161 and OR 162 with F' strains that carry episomes Flo or F112 (see Table 1 ), selecting for Arg+ conjuguants (see Fig. 2 ). These merodipldids (OR 161-10 and OR 162-10 with F11o. and OR 161-12
and OR 162-12 with F112) were grown either in the absence or in the presence of lysine and without arginine, which is the selective marker for the episome; AK III and ASA-dehydrogenase specific activities were measured. Results are given in Table 5 . AK III specific activity is given either as "lysine-sensitive activity" (specified by lysC genes of strain OR 161 and of episomes) or "lysine-desensitized activity" (specified by the lysC gene of strain OR 162). Though F' strains carry the metLM gene, which specifies AK II enzyme (21) b Activity inhibited by lysine corresponds to the difference between total aspartokinase activity (assay in the absence of inhibitors) and activity assayed in the presence of lysine.
c Activity desensitized towards lysine corresponds to aspartokinase activity assayed in the presence of lysine (no difference between total activity and activity assayed in the presence of lysine).
tially derepressed level of enzyme when the merodiplofds are cultured under repressed conditions; however, this level is significantly lower (approximately one-half) than found in the parental strain OR 161. To see if this effect is cis or trans dominant, we have used strains OR 162-10 and OR 162-12, in which the episome carries a lysC+ gene, and the chromosome carries the lys-1100 mutation and a lysC1012 mutation that specifies a desensitized AK III (the use of a desensitized mutation for dominance studied has been already proposed by Mattern and Pittard [12 ] ). It can be seen in Table 5 that only desensitized AK III activity is observed in repressed conditions; thus, the gene in trans that specifies an inhibitable AK III is normally repressed. In fact, it is also repressed even in minimal medium; this is ex-plained by the existence of a high lysine internal pool, as usually is observed in strains possessing a desensitized AK III (2). This repression phenomenon in minimal medium also is observed for the desensitized AK III activity (24 units instead of 120 for the non-desensitized dipldid) and ASA-dehydrogenase activity (402 units instead of 865). It must be noted that, in this case also (growth being always effected in the absence of arginine), the partially repressed level was lower than with the parental strain OR 162. It has been verified that the episome was always present in all these strains, by subsequent conjugation with an F-arg-lysC-strain and selection of Arg+ LysC + conjugants.
The fact that the partially repressed level was lower in the diploids than with the parental strain was further studied. We have shown that it is not due to the presence of a lysC+ allele on the episome, by the use of episome F,4 which does not carry this gene (Fig. 2) , but is Ile+ and Arg+, allowing an Ile+ selection. Merodiplofds OR 161-14 and OR 162-14 were prepared as described above. When these strains were grown in the absence of arginine, the repressed level of the other dipldids was obtained, though when grown in the presence of arginine the level of the parental strains OR 161 or OR 162 was again observed, indicating a possible role of arginine.
To ensure that the presence of the episome is not involved in the phenomenon, strain DO 6, an Arg+ derivative of strain ORA 101, was prepared (Table 1) . AK III specific activity was determined on cultures grown in repressed conditions in the presence or absence of arginine. With this strain also, a more repressed level was observed in the absence of arginine ( Table 5 ), confirming that this amino acid is involved in the repression phenomenon.
DISCUSSION
To select regulatory mutants in the lysine biosynthetic pathway, a parental strain has been prepared that has the following characteristics: AK I and AK II activities are absent; AK III activity is no longer sensitive to lysine inhibition; ASA-dehydrogenase is leaky (Fig.  1 ). Owing to this last mutation, growth of this strain is inhibited by adding lysine to the medium at a high concentration, thus allowing the selection of mutants resistant to this lysine inhibition of growth; similar procedures have already been used by Roth et al. (18) in the case of the histidine pathway and Jacoby and Gorini (7) for the arginine pathway. This resistance could not be due to the desensitization of AK III, the main regulatory mechanism (2) in this system, since such a mutation is already present in the strain.
Among the different possibilities leading to resistance to lysine, one may think either of reversion to a normal ASA-dehydrogenase activity or of mutants with defects in lysine permeation or regulatory mutants. This last class may comprise: (i) constitutive mutants for lysine-decarboxylase synthesis (which will rapidly destroy lysine); (ii) constitutive mutants for ASA-dehydrogenase synthesis; (iii) constitutive mutants for AK III synthesis; (iv) derepressed mutants for the synthesis of all the genes of the regulon. In approximately 10% of the 200 mutants tested, a derepressed synthesis of AK III was observed in minimal medium; but this effect of derepression appeared phenotvpic, because normal repression could be obtained. These mutants are not yet identified. A possible role of lysyl-transfer ribonucleic acid, the concentration of which may be lowered in these strains, appears unlikely; recent results in our laboratory on a lysyl-transfer ribonucleic acid synthetase mutant indicate that modification in the percentage of lysyl-transfer ribonucleic acid charged in vivo does not affect the synthesis of AK III (unpublished data).
Only strain ORA 11 (ORA 19 appeared to be identical) showed a phenotype that could be genetically identified. The lys-IJOO mutation in this strain appears to be a cis-dominant constitutive one for AK III synthesis, for the following reasons. (i) The derepression of synthesis, maximal in minimal medium, is not total when the strain is grown in the presence of an excess of lysine (Table 3) , as is frequently the case for cis-dominant constitutive mutants identified as operator constitutive. (ii) This mutation has no effect on the synthesis of two other enzymes of the pathway, ASA-dehydrogenase and diaminopimelate decarboxylase (Table 4 ). In fact, an effect of this mutation on the synthesis of the diaminopimelate decarboxylase can be observed, but only in the simultaneous presence of a mutation leading to the desensitization of AK III towards lysine; this phenomenon is explained by an inducible role of the AK III protein itself on the diaminopimelate decarboxylase synthesis (13) . (iii) The mutation is dominant over the wild-type allele (derepression of AK III in merodipldfds) but only in the cis position: in a merodiplofd in which a lysC desensitized mutation is in cis position with lys-1100 and in which the episome carries the two wild-type alleles only the desensitized activity is derepressed (Table 5 ). (iv) These results could also be explained by a promoter-up mutation. This is unlikely. We have prepared (data not shown) lysine auxotrophs of' strains ORA 101 and Gif' 106; when the growth of' these auxotrophic strains was limited by lvsine supply in the chemostat, similar derepressed AK III specif'ic activity was obtained in both strains and no increase was observed in the derepressed level of' the mutant, as would be expected for a promoter-up mutation.
Some additional points should be emphasized. The AK III protein purified f'rom strains carrying the lys-1100 mutation is identical by all criteria tested, to the enzyme purif'ied from the wild-type strain; strain DO 6 was thus already used as a source of bacteria in order to purify the AK III protein, allowing the preparation of' 400 mg of' pure AK III from 1 kg of frozen cells (18) .
The f'act that the growth of strain ORA 101, which carries this constitutive mutation with a lvsC-gene, is inhibited by lysine supports the idea (2) that lysine inhibition of' AK III activity appears to be the essential point of regulation in the pathway.
In addition, we have shown that arginine in the medium affects the maximal level of repression obtained; the effect of repression by lysine is less important in the presence of' this amino acid than in its absence (Table 5 ). Preliminary experiments indicate that an effect on permeation through the common permease (3) is not involved and that the phenomenon appears rather specific for arginine. A direct role of arginine in the repression by lysine may thus occur and may represent another example of the "metabolism interlock" as def'ined by Jensen (8) . This possibility is currently under study.
We have made numerous attempts to select mutants in which regulation in the lysine pathway was altered, using different standard procedures (such as the use of' lysine analogues); all were unsuccessful until now. The cis-dominant constitutive mutant described here is the first mutant with altered regulation of synthesis identified in this pathway in E. coli K-12. However, here again, among the numerous clones tested, none appeared to be affected in a common repressor molecule (R type). These observations, though negative, may lead to different possibilities. Either the methods of selection are not sufficient (this appears not to be true in the present case); or no R molecule exists; or the R molecule plays an essential role and its alteration is lethal; or different molecules are involved for the different genes. The recent observation that AK III protein acts as an inducer of the diaminopimelate decarboxylase synthesis (13) indicates that the latter two possibilities are likely to be involved.
